Healthcare · Medical - Devices
Price
$332.31
Market Cap
$127.4B
Employees
53,000
Beta
0.79
Avg Volume
2,513,138
CEO
Kevin A. Lobo
Business Description
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Business History
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
APIStock Price / EPS (Diluted)
38.13
Stock Price: $332.31
EPS (Diluted): 8.49
EPS (Diluted): 8.49
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
5.99
Stock Price: $332.31
Total Equity: $22.42B
Shares: 382,200,000
Total Equity: $22.42B
Shares: 382,200,000
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
22.68
Market Cap: $127.39B
Total Debt: $16.01B
Cash: $4.01B
EBITDA: $6.31B
Total Debt: $16.01B
Cash: $4.01B
EBITDA: $6.31B
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$146.7B
Market Cap: $127.39B
Total Debt: $16.01B
Cash: $4.01B
Total Debt: $16.01B
Cash: $4.01B
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
64.0%
Gross Profit: $16.07B
Revenue: $25.12B
Revenue: $25.12B
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
19.5%
Operating Income: $4.89B
Revenue: $25.12B
Revenue: $25.12B
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
12.9%
Net Income: $3.25B
Revenue: $25.12B
Revenue: $25.12B
ROE (Profit from shareholder equity)
APINet Income / Total Equity
15.1%
Net Income: $3.25B
Total Equity: $22.42B
Total Equity: $22.42B
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
9.6%
Operating Income: $4.89B
Tax Rate: 28.1%
Equity: $22.42B
Total Debt: $16.01B
Cash: $4.01B
Tax Rate: 28.1%
Equity: $22.42B
Total Debt: $16.01B
Cash: $4.01B
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
1.89
Current Assets: $14.76B
Current Liabilities: $7.79B
Current Liabilities: $7.79B
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.71
Short-Term Debt: $1.15B
Long-Term Debt: $14.86B
Total Debt: $16.01B
Total Equity: $22.42B
Long-Term Debt: $14.86B
Total Debt: $16.01B
Total Equity: $22.42B
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$65.71
Revenue: $25.12B
Shares: 382,200,000
Shares: 382,200,000
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$58.66
Total Equity: $22.42B
Shares: 382,200,000
Shares: 382,200,000
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$11.21
Operating CF: $5.04B
CapEx: -$761.00M
Shares: 382,200,000
CapEx: -$761.00M
Shares: 382,200,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
1.0%
Last Dividend: N/A
Stock Price: $332.31
Stock Price: $332.31
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: $3.25B
Net Income: $3.25B
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares SYK against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 23, 2026 3:02am (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $17.1B | $18.4B | $20.5B | $22.6B | $25.1B |
| Cost of Revenue | $6.4B | $7.4B | $8.0B | $8.6B | $9.1B |
| Gross Profit | $10.7B | $11.0B | $12.5B | $14.0B | $16.1B |
| Operating Expenses | $6.9B | $7.3B | $8.2B | $8.9B | $11.2B |
| Operating Income | $3.8B | $3.7B | $4.3B | $5.1B | $4.9B |
| Net Income | $2.0B | $2.4B | $3.2B | $3.0B | $3.2B |
| EBITDA | $3.6B | $4.0B | $5.1B | $4.9B | $6.3B |
| EPS | $5.29 | $6.23 | $8.34 | $7.86 | $8.49 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 23, 2026 3:02am (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2.9B | $1.8B | $3.0B | $3.7B | $4.0B |
| Total Current Assets | $10.0B | $10.3B | $12.5B | $14.8B | $14.8B |
| Total Assets | $34.6B | $36.9B | $39.9B | $43.0B | $47.8B |
| Current Liabilities | $4.5B | $6.3B | $7.9B | $7.6B | $7.8B |
| Long-Term Debt | $12.5B | $11.9B | $10.9B | $12.2B | $14.9B |
| Total Liabilities | $19.8B | $20.3B | $21.3B | $22.3B | $25.4B |
| Total Equity | $14.9B | $16.6B | $18.6B | $20.6B | $22.4B |
| Retained Earnings | $13.5B | $14.8B | $16.8B | $18.5B | $20.5B |
Cash Flow (Annual)
Last updated: Jun 23, 2026 3:02am (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3.3B | $2.6B | $3.7B | $4.2B | $5.0B |
| Capital Expenditure | -$525.0M | -$588.0M | -$575.0M | -$755.0M | -$761.0M |
| Free Cash Flow | $2.7B | $2.0B | $3.1B | $3.5B | $4.3B |
| Acquisitions (net) | -$339.0M | -$2.6B | -$390.0M | -$1.6B | -$4.8B |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$114.0M | -$122.0M | -$155.0M | -$195.0M | $0 |
| Net Change in Cash | $1.0M | -$1.1B | $1.1B | $681.0M | $359.0M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 4:59am (4h ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$29.6B $29.0B – $29.9B
|
$32.0B $32.0B – $32.0B
|
$34.9B $34.4B – $35.2B
|
$38.0B $37.5B – $38.3B
|
| EBITDA |
$6.8B $6.6B – $6.8B
|
$7.3B $7.3B – $7.3B
|
$8.0B $7.9B – $8.1B
|
$8.7B $8.6B – $8.8B
|
| Net Income |
$6.2B $5.9B – $6.5B
|
$7.2B $6.6B – $7.8B
|
$8.0B $7.9B – $8.1B
|
$8.9B $8.7B – $9.0B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 23, 2026 3:02am (4d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +7.8% | +11.1% | +10.2% | +11.2% |
| Gross Profit Growth | +3.1% | +13.2% | +11.9% | +14.9% |
| Operating Income Growth | -0.8% | +14.6% | +18.2% | -3.4% |
| Net Income Growth | +18.3% | +34.2% | -5.4% | +8.5% |
| EBITDA Growth | +11.4% | +25.9% | -2.4% | +27.9% |
Insider Trading (Recent)
Last updated: Jun 27, 2026 4:59am (4h ago)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-01 | Stiles Spencer S | G-Gift | 1,607.00 | $0.00 | $0 |
| 2026-05-28 | Fletcher Robert S | S-Sale | 120.00 | $304.23 | $36,507 |
| 2026-05-28 | Fletcher Robert S | S-Sale | 165.00 | $305.66 | $50,434 |
| 2026-05-28 | Fletcher Robert S | S-Sale | 2,809.00 | $306.56 | $861,138 |
| 2026-05-28 | Fletcher Robert S | S-Sale | 1,067.00 | $307.30 | $327,886 |
| 2026-05-28 | Fletcher Robert S | S-Sale | 258.00 | $308.79 | $79,667 |
| 2026-05-28 | Fletcher Robert S | S-Sale | 125.00 | $310.22 | $38,778 |
| 2026-05-26 | STRYKER RONDA E | S-Sale | 3,707.00 | $315.11 | $1.2M |
| 2026-05-26 | STRYKER RONDA E | S-Sale | 21,807.00 | $310.77 | $6.8M |
| 2026-05-26 | STRYKER RONDA E | S-Sale | 115,960.00 | $311.60 | $36.1M |
| 2026-05-26 | STRYKER RONDA E | S-Sale | 114,059.00 | $312.44 | $35.6M |
| 2026-05-26 | STRYKER RONDA E | S-Sale | 44,060.00 | $313.35 | $13.8M |
| 2026-05-26 | STRYKER RONDA E | S-Sale | 10,407.00 | $314.38 | $3.3M |
| 2026-05-08 | Fink M Kathryn | M-Exempt | 11,850.00 | $179.35 | $2.1M |
| 2026-05-08 | Fink M Kathryn | M-Exempt | 9,732.00 | $154.14 | $1.5M |
| 2026-05-08 | Fink M Kathryn | F-InKind | 16,362.00 | $294.23 | $4.8M |
| 2026-05-11 | Fink M Kathryn | S-Sale | 5,220.00 | $283.85 | $1.5M |
| 2026-05-11 | Fink M Kathryn | S-Sale | 3,500.00 | $283.45 | $992,086 |
| 2026-05-08 | Fink M Kathryn | M-Exempt | 9,732.00 | $154.14 | $1.5M |
| 2026-05-08 | Fink M Kathryn | M-Exempt | 11,850.00 | $179.35 | $2.1M |
Dividend History (Last 20)
Last updated: Jun 21, 2026 7:05pm (5d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-06-30 | $0.88 | 2026-05-06 | 2026-06-30 | 2026-07-31 |
| 2026-03-31 | $0.88 | 2026-02-04 | 2026-03-31 | 2026-04-30 |
| 2025-12-31 | $0.88 | 2025-12-11 | 2025-12-31 | 2026-01-30 |
| 2025-09-30 | $0.84 | 2025-08-07 | 2025-09-30 | 2025-10-31 |
| 2025-06-30 | $0.84 | 2025-05-08 | 2025-06-30 | 2025-07-31 |
| 2025-03-31 | $0.84 | 2025-02-05 | 2025-03-31 | 2025-04-30 |
| 2024-12-31 | $0.84 | 2024-12-10 | 2024-12-31 | 2025-01-31 |
| 2024-09-30 | $0.80 | 2024-08-07 | 2024-09-30 | 2024-10-31 |
| 2024-06-28 | $0.80 | 2024-05-09 | 2024-06-28 | 2024-07-31 |
| 2024-03-27 | $0.80 | 2024-02-07 | 2024-03-29 | 2024-04-30 |
| 2023-12-28 | $0.80 | 2023-12-05 | 2023-12-29 | 2024-01-31 |
| 2023-09-28 | $0.75 | 2023-08-02 | 2023-09-29 | 2023-10-31 |
| 2023-06-29 | $0.75 | 2023-05-10 | 2023-06-30 | 2023-07-31 |
| 2023-03-30 | $0.75 | 2023-02-09 | 2023-03-31 | 2023-04-28 |
| 2022-12-29 | $0.75 | 2022-12-07 | 2022-12-30 | 2023-01-31 |
| 2022-09-29 | $0.70 | 2022-08-03 | 2022-09-30 | 2022-10-31 |
| 2022-06-29 | $0.70 | 2022-05-04 | 2022-06-30 | 2022-07-29 |
| 2022-03-30 | $0.70 | 2022-02-02 | 2022-03-31 | 2022-04-29 |
| 2021-12-30 | $0.70 | 2021-12-09 | 2021-12-31 | 2022-01-31 |
| 2021-09-29 | $0.63 | 2021-08-04 | 2021-09-30 | 2021-10-29 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for SYK — it's generated by the pipeline (
market-narrative step).
No community reviews yet for SYK.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30